HIGHLIGHTS
SUMMARY
Detection of vascular regenerative cell exhaustion is required to combat ischemic complications during type 2 diabetes mellitus (T2D). We used high aldehyde dehydrogenase (ALDH) activity and surface marker coexpression to develop a high-throughput flow cytometry-based assay to quantify circulating proangiogenic and proinflammatory cell content in the peripheral blood of individuals with T2D. Circulating proangiogenic monocytes expressing anti-inflammatory M2 markers were decreased in patients with T2D. Individuals with longer duration of T2D exhibited reduced frequencies of circulating proangiogenic ALDH Although newer antihyperglycemic agents reportedly improve cardiovascular outcomes in diabetes (5-15), the unmet need and residual risk remain prohibitively high in T2D (16) .
To minimize the risks associated with reduced blood flow causing ischemia, multiple endogenous mechanisms can be activated to reverse vascular dysfunction (4). These multicellular processes include vasculogenesis, the creation of de novo vessels from endothelial progenitor cells; angiogenesis, the sprouting of new blood vessels from pre-existing vessels; and arteriogenesis, the beneficial remodeling of pre-existing collateral vessels to form a "natural bypass" toward the ischemic region (4,17).
Although angiogenesis and postnatal vasculogenesis have been widely studied, both processes can be limited in adults by the scarcity of circulating provascular progenitor cells of hematopoietic and endothelial lineages (18, 19) . Although arteriogenesis is not as well understood, accessory immune cells (including monocytes and macrophages) are recruited to pre-existing collateral vessels and participate in vessel remodeling to activate blood flow (4, 18, 20, 21) .
Thus, these processes rely on structural and secretory contributions from circulating hematopoietic and endothelial cells that originate from the BM (22,23). In the context of T2D, the impact of glucotoxicity and phenotype suggested increased inflammation in patients with T2D. In addition, more sensitive analyses using multiple markers combined with ALDH-activity was required to accurately detect differences in circulating proangiogenic progenitor cell frequencies. (40) Values are mean AE SEM or n (%). *p < 0.001 with the Student's t-test.
HbA1c ¼ glycosylated hemoglobin; HDL-C ¼ high-density lipoprotein cholesterol; LDL-C ¼ lowdensity lipoprotein cholesterol; NA ¼ not applicable; T2D ¼ type 2 diabetes mellitus. Figure 1B . Importantly, The frequency of cells expressing mature and primitive hematopoietic and endothelial markers was equal in patients with type 2 diabetes mellitus (T2D) compared with age, gender, and sex-matched control subjects. The frequency of cells expressing the monocyte/macrophage marker CD14 was decreased in patients with T2D compared with control subjects. The frequency of cells expressing the M1 macrophage marker CD80 (pro-inflammatory phenotype) was increased whereas the frequency of cells expressing the M2 macrophage marker CD163 (anti-inflammatory phenotype) was decreased in patients with T2D compared with control subjects. Values are mean AE SEM. Statistical comparisons were conducted with the Student's t-test.
high (R3) SSC as shown in
CTLA-4 ¼ cytotoxic T-lymphocyte associated protein 4; IgG ¼ immunoglobulin G.
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( Figures 3D to 3I ). Cells expressing these markers are required for vasculogenic vessel formation (40) .
These findings were also consistent with the depletion of proangiogenic circulating cell content, potentially leading to a dysfunctional vascular regenerative response in patients with T2D. Terenzi et al.
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contrast, M1 macrophages generally contribute toward inflammatory processes that may impede new vessel progression (18, 43, 45 
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Circulating ALDH hi Cells Are Decreased in T2D more advanced T2D whereby glycemia is not controlled by diet, exercise, and medication. There was a significant decrease in the frequency of circulating pro-inflammatory ALDH hi SSC hi granulocytes in patients receiving insulin therapy ( Figures 5A and 5B ).
These data suggested reduced inflammation in patients who received insulin therapy; however, circulating primitive progenitor cell frequencies were not affected by insulin use ( Figures 5C and 5D ). The frequency of primitive and migratory progenitor cells was equivalent in patients with T2D despite insulin therapy. Values are mean AE SEM. *p < 0.05 with the Student's t-test. Abbreviations as in Figure 1 .
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DISCUSSION
The current study presents a novel diagnostic flow cytometry assay, using high ALDH-activity, a func- Collectively, these data suggest that a prolonged duration of T2D promotes a pro-inflammatory milieu, affecting both granulocytes and monocytes, in addition to depletion of rare progenitor cells shown previously to coordinate proangiogenic blood vessel repair in animal models (23, 35, 48, 54, 55) .
The overall frequency of ALDH hi SSC low progenitor cells or CD34-expressing cells was surprisingly not decreased in patients with T2D compared with the control subjects. Selection for cells with high ALDH-activity (4,56) or CD34 expression (30, 32, 57, 58) has been used in clinical trials as highly purified cell populations transplanted from autologous BM to combat ischemic disease. In contrast, a significant reduction in the frequency of circulating monocytes (33, 42, 43 ) with anti-inflammatory M2 phenotype (31, 59, 60) was easily detected in patients with T2D.
These observations may be attributed to differences in the relative frequencies of circulating cells in the To our knowledge, the current study is the first to clearly document the depletion of circulating provascular progenitor cell content by using ALDHactivity during established T2D in human subjects. Terenzi et al. The potential of developing this assay into a diagnostic tool to estimate the capacity to mitigate ischemia via a provascular regenerative response represents an exciting avenue for exploration and will need to be investigated.
